BIOCEPT, INC. Deferred Tax Assets, Gross
BIOCEPT, INC. had Deferred Tax Assets, Gross of $33.04 million as of 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2023-04-17
- 2022-12-31: Deferred Tax Assets, Gross $33.04M.
- 2021-12-31: Deferred Tax Assets, Gross $26.38M.
- 2020-12-31: Deferred Tax Assets, Gross $28.10M; Deferred Tax Assets, Gross as first filed $28.10M.
- 2019-12-31: Deferred Tax Assets, Gross $21.18M; Deferred Tax Assets, Gross as first filed $21.18M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2022-12-31 | $33.04M 10-K · filed 2023-04-17 | |
| 2021-12-31 | $26.38M 10-K · filed 2023-04-17 | |
| 2020-12-31 | $28.10M 10-K · filed 2022-04-05 | $28.10M 10-K · filed 2021-03-31 |
| 2019-12-31 | $21.18M 10-K · filed 2021-03-31 | $21.18M 10-K · filed 2020-03-27 |
| 2018-12-31 | $15.12M 10-K · filed 2020-03-27 | |
| 2017-12-31 | $9.04M 10-K · filed 2019-03-29 | $8.69M 10-K · filed 2018-03-28 |
| 2016-12-31 | $6.90M 10-K · filed 2018-03-28 | |
| 2015-12-31 | $9.86M 10-K · filed 2017-03-28 | |
| 2014-12-31 | $53.99M 10-K · filed 2016-03-10 | |
| 2013-12-31 | $49.70M 10-K · filed 2015-03-11 |